NASDAQ: SHLT - SHL Telemedicine Ltd.

Rentabilité sur six mois: -42.75%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions SHL Telemedicine Ltd.


À propos de l'entreprise SHL Telemedicine Ltd.

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center.

plus de détails
The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. It offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. The company serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.

IPO date 2023-04-03
ISIN US78423T2006
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.shl-telemedicine.com
Цена ао 2.1
Changement de prix par jour: 0% (1.9236)
Changement de prix par semaine: -23.06% (2.5)
Changement de prix par mois: -13.35% (2.22)
Changement de prix sur 3 mois: -36.51% (3.03)
Changement de prix sur six mois: -42.75% (3.36)
Changement de prix par an: -68.47% (6.1)
Evolution des prix depuis le début de l'année: -35.99% (3.005)

Sous-estimation

Nom Signification Grade
P/S 2.35 6
P/BV 1.75 8
P/E 0 0
EV/EBITDA 166.59 1
Total: 4.63

Efficacité

Nom Signification Grade
ROA, % -6.23 0
ROE, % -9.57 0
Total: 0.1667

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0.8014

Devoir

Nom Signification Grade
Debt/EBITDA 17.09 0
Total: 6

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 36.22 5
Rentabilité Ebitda, % -64.31 0
Rentabilité EPS, % -179.99 0
Total: 1



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Amir Hai Chief Financial Officer N/A 1966 (59 années)
Mr. Bernd Altpeter Managing Director of SHL Telemedizin Germany N/A
Mr. David Arnon Chief Executive Officer 1970 (55 années)

Adresse: Israel, Tel Aviv, Ashdar Building - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.shl-telemedicine.com